These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18728740)

  • 1. Update on the use of pramipexole in the treatment of Parkinson's disease.
    Constantinescu R
    Neuropsychiatr Dis Treat; 2008 Apr; 4(2):337-52. PubMed ID: 18728740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease.
    Bennett JP; Piercey MF
    J Neurol Sci; 1999 Feb; 163(1):25-31. PubMed ID: 10223406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease.
    Piercey MF
    Clin Neuropharmacol; 1998; 21(3):141-51. PubMed ID: 9617505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pramipexole. A review of its use in the management of early and advanced Parkinson's disease.
    Dooley M; Markham A
    Drugs Aging; 1998 Jun; 12(6):495-514. PubMed ID: 9638397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New pharmacotherapy for Parkinson's disease.
    Gottwald MD; Bainbridge JL; Dowling GA; Aminoff MJ; Alldredge BK
    Ann Pharmacother; 1997 Oct; 31(10):1205-17. PubMed ID: 9337447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
    Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D
    Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotigotine transdermal system for the treatment of Parkinson's disease.
    Pham DQ; Nogid A
    Clin Ther; 2008 May; 30(5):813-24. PubMed ID: 18555929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
    Utsumi H; Okuma Y; Kano O; Suzuki Y; Iijima M; Tomimitsu H; Hashida H; Kubo S; Suzuki M; Nanri K; Matsumura M; Murakami H; Hattori N;
    Intern Med; 2013; 52(3):325-32. PubMed ID: 23370739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study.
    Pinter MM; Pogarell O; Oertel WH
    J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):436-41. PubMed ID: 10201413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pramipexole-induced somnolence and episodes of daytime sleep.
    Hauser RA; Gauger L; Anderson WM; Zesiewicz TA
    Mov Disord; 2000 Jul; 15(4):658-63. PubMed ID: 10928575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pramipexole for the treatment of early Parkinson's disease.
    Perez-Lloret S; Rey MV; Ratti L; Rascol O
    Expert Rev Neurother; 2011 Jul; 11(7):925-35. PubMed ID: 21721909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Sleep attacks' or 'unintended sleep episodes' occur with dopamine agonists: is this a class effect?
    Chaudhuri KR; Pal S; Brefel-Courbon C
    Drug Saf; 2002; 25(7):473-83. PubMed ID: 12093305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
    Parkinson Study Group
    JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease.
    Holtz NA; Tedford SE; Persons AL; Grasso SA; Napier TC
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():77-84. PubMed ID: 27216282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Efficacy of Different Drugs on Non-Motor Symptoms of Parkinson's Disease: a Network Meta-Analysis.
    Li BD; Cui JJ; Song J; Qi C; Ma PF; Wang YR; Bai J
    Cell Physiol Biochem; 2018; 45(1):119-130. PubMed ID: 29339630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
    Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A;
    Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the risk of adverse events with pramipexole and ropinirole in patients with Parkinson's disease: a meta-analysis.
    Etminan M; Gill S; Samii A
    Drug Saf; 2003; 26(6):439-44. PubMed ID: 12688834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of pramipexole in Parkinson's disease: are its actions D(3) mediated?
    Guttman M; Jaskolka J
    Parkinsonism Relat Disord; 2001 Jul; 7(3):231-234. PubMed ID: 11331191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piribedil-induced sleep attacks in Parkinson's disease.
    Tan EK
    Fundam Clin Pharmacol; 2003 Feb; 17(1):117-9. PubMed ID: 12588638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons.
    Hall ED; Andrus PK; Oostveen JA; Althaus JS; VonVoigtlander PF
    Brain Res; 1996 Dec; 742(1-2):80-8. PubMed ID: 9117424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.